Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years
Liebhaber, H.; Ingalls, T.H.; Le Bouvier, G.L.; Horstmann, D.M.
American Journal of Diseases of Children 123(2): 133-136
1972
ISSN/ISBN: 0002-922X PMID: 4554549 Document Number: 45228
Document emailed within 1 workday
Related Documents
Trier, H.; Rønne, T. 1992: Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella Ugeskrift for Laeger 154(29): 2008-2013Zourbas, J.; Colas, J.; Boivin, M. 1983: Rubella immunity 6 to 10 years following vaccination of previously seronegative young girls Presse Medicale 12(11): 701
Vázquez Fernández, E.; López Rois, F.; Vázquez Carrete, J.A.; Gómez Tato, B.; Alvarez Ares, M. 1987: Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old Anales Espanoles de Pediatria 27(1): 27-31
Naficy, K.; Nategh, R.; Ahangary, S.; Mohsenin, H. 1970: Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children American Journal of Diseases of Children 120(6): 520-523
Redmann, T.; Buken, B.; Kaleta, E.F.; Luders, H.; Siegmann, O. 1983: Vaccination against infectious laryngotracheitis of chickens: determination of immunity following eyedrop or spray vaccination using serology and challenge infections Deutsche Tierärztliche Wochenschrift 90(4): 137-141
da Silveira, C.Marcos.; Kmetzsch, C.Iris.; Mohrdieck, R.; Sperb, A.Fagundes.; Prevots, D.Rebecca. 2002: The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997 International Journal of Epidemiology 31(5): 978-982
Muntiu, N.; Dumitrescu, A.; Dohotaru, V.; Negrutiu, T.; Bercan, A.; Mircescu, G.; Stirbu, C.; Tomescu, A. 1972: Duration of post-vaccination immunity against foot-and-mouth disease in relation to animal age, vaccine dose and vaccination repetition (recurrence effect) Bulletin - Office International des Epizooties 77(5): 771-787
Hofmann, H.; Karsai, I.; Prunner, C. 1975: The choice of vaccine for post partum rubella vaccination Wiener Klinische Wochenschrift 87(10): 332-333
Shi, O.S. 1981: Observations on immune persistence after vaccination with attenuated polio vaccine Zhonghua Yu Fang Yi Xue Za Zhi 15(3): 148-150
abu Eldan, J.; Borćić, B.; Smerdel, S. 1991: Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine Acta medica Croatica: casopis Hravatske akademije medicinskih znanosti 45(4-5): 297-304
Wang, S.; Wu, C.; Li, Y. 1994: Evaluation on efficacy of plasma-derived hepatitis B vaccine and persistence of protective level after vaccination Zhonghua Liu Xing Bing Xue Za Zhi 15(3): 154-157
Pessoa, S.D.; Miyamoto, M.; Ono, E.; Gouvêa, A.íd.F.T.B.; de Moraes-Pinto, M.I.; Succi, R.C.M. 2010: Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART Vaccine 28(6): 1606-1612
Miller, E.; Waight, P.; Gay, N.; Ramsay, M.; Vurdien, J.; Morgan-Capner, P.; Hesketh, L.; Brown, D.; Tookey, P.; Peckham, C. 1997: The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme Communicable Disease Report. Cdr Review 7(2): R26-R32
Jirjis, F.F.; Davis, T.; Lane, J.; Carritt, K.; Sweeney, D.; Williams, J.; Wasmoen, T. 2010: Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine Veterinary Therapeutics: Research in Applied Veterinary Medicine 11(2): E1-E6
Paul, P.S.; Mengeling, W.L. 1986: Vaccination of swine with an inactivated porcine parvovirus vaccine in the presence of passive immunity Journal of the American Veterinary Medical Association 188(4): 410-413
Heller, T. 2001: Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? how safe is MMR vaccine? Bmj 323(7317): 838-839; Discussion 840
Kopeć, J.; Zgórniak-Nowosielska, I. 1994: Incidence of rubella antibodies and the results of vaccination against rubella in young women Przeglad Epidemiologiczny 48(4): 475-479
Malakmadze, N.; Zimmerman, L.A.; Uzicanin, A.; Shteinke, L.; Caceres, V.M.; Kasymbekova, K.; Sozina, I.; Glasser, J.W.; Joldubaeva, M.; Aidyralieva, C.; Icenogle, J.P.; Strebel, P.M.; Reef, S.E. 2004: Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001 Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 38(12): 1780-1783
Namaei, M.H.; Ziaee, M.; Naseh, N. 2008: Congenital rubella syndrome in infants of women vaccinated during or just before pregnancy with measles-rubella vaccine Indian Journal of Medical Research 127(6): 551-554
McLeod, R.; Frenkel, J.K.; Estes, R.G.; Mack, D.G.; Eisenhauer, P.B.; Gibori, G. 1988: Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge Journal of Immunology 140(5): 1632-1637